<DOC>
	<DOCNO>NCT01383135</DOCNO>
	<brief_summary>The purpose study conduct pilot test new tracer healthy human volunteer define normal tracer biodistribution ( tracer go ) , stability ( much metabolises ) , pharmacokinetics ( much stay organ long ) , radiation dosimetry ( organ radiation dose ) . The radiopharmaceutical tested cancer patient .</brief_summary>
	<brief_title>Biodistribution Safety PET Probes 18FFPRGD2 18FFPPRGD2</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Glioblastoma</mesh_term>
	<criteria>Healthy volunteer : 1 . Must 18 year age old . 2 . Must know medical problem full medical exam within 6 month study . 3 . Must understand voluntarily sign Informed Consent content fully explain . 4 . Women child bear potential ( defined woman post menopausal 12 month previous surgical sterilization ) men must agree use adequate contraception ( hormonal barrier method birth control ; abstinence ) prior study entry , duration study participation 30 day last dose . Cancer subject : 1 . Greater 18 yearsold time radiotracer administration 2 . Provides write informed consent 3 . Diagnosed advanced NSCLC , breast cancer , pancreatic cancer GBM ; patient undergo bevacizumab Cyberknife therapy 4 . Able remain still duration image procedure ( one hour ) Exclusion Criteria 1 . Less 18 yearsold time radiotracer administration 2 . Pregnant nursing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Healthy volunteer</keyword>
</DOC>